Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Potential treatments of COVID-19: Drug repurposing and therapeutic interventions

Journal of Pharmacological Sciences(2023)10.1016/j.jphs.2023.02.004Source: DataRank Database

Potential treatments of COVID-19: Drug repurposing and therapeutic interventions is a research paper published in Journal of Pharmacological Sciences (2023). On theSindex it has a DataRank of 0. It has been cited 20 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access20 citations

Download PDF

Cite:

Linked data & code

eudract nct pdb doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 3.40)OA: goldTopics (41)IDs (PubMed, PMC, OpenAlex)Annotations (4)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Zoya Mann ORCID,Simran Kaur Ahluwalia,Raja Rajalingam ORCID,Pawan Kumar Raghav ORCID

Live enrichment

PubMed:37059487 PMC:PMC9930377 OpenAlex:https://openalex.org/W4320913192

U.S. National Library of Medicine

University of California, San Francisco

National Institutes of Health

FWCI

3.40

Citation Percentile

0.9%

Citation Trend

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://doi.org/10.1016/j.jphs.2023.02.004

publisherhttps://doi.org/10.1016/j.jphs.2023.02.004

publisherhttps://api.elsevier.com/content/article/PII:S1347861323000099?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1347861323000099?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/37059487

Fields of Study

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesLong-Term Effects of COVID-19HumansCOVID-19SARS-CoV-2Drug RepositioningCOVID-19 Drug TreatmentPeptidyl-Dipeptidase AProtein Binding

MeSH Terms

COVID-19SARS-CoV-2COVID-19 Drug TreatmentHumansPeptidyl-Dipeptidase AProtein BindingDrug Repositioning

Keywords

Drug repositioningRepurposingCoronavirus disease 2019 (COVID-19)PandemicMedicineDrugCoronavirusAngiotensin-converting enzyme 2Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Drug developmentClinical trialPharmacology2019-20 coronavirus outbreakIntensive care medicineVirologyDiseaseInfectious disease (medical specialty)BiologyInternal medicineVaccinesClinical TrialsDrug RepurposingCovid-19Sars-cov-2

Sustainable Development Goals

SDG 0: Good health and well-being

Potential treatments of COVID-19: Drug repurposing and therapeutic interventions

FAIR Checklist

Authors (4)

Funding (3 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)